AI Science Tracker
EN

Ultrasound neural maps identify pathology-defined prostate cancer tissue

Eindhoven University of Technology; Amsterdam UMC; Leiden University Medical Center; Angiogenesis Analytics · 30 Jan 2026 · medicine

Discovery

Ultrasound neural maps identify pathology-defined prostate cancer tissue

Source check: Source checked. Not independent scientific confirmation.

Finding: A three-dimensional CNN and multilayer perceptron combined quantitative ultrasound features to map clinically significant prostate cancer. Development involved 250 patients, followed by 77 later-enrolled patients; reported voxel-level AUC was 0.884 in that later group. Pathology registration and a surgical-enriched cohort limit interpretation. This does not establish patient-level diagnostic accuracy, biopsy benefit or equivalence to MRI-guided care.

Technology: Three-dimensional convolutional neural network; multilayer perceptron

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Three CNN feature branches learn ultrasound patterns and an MLP combines them into voxel-level cancer probability maps.
Test and result
Patient-partitioned development and temporally separate same-centre testing, using reconstructed prostatectomy pathology or negative MRI/biopsy references.
Limitation / still unknown
Lesion/patient-level clinical performance and treatment benefit remain unestablished; entire-dataset feature standardization and registration uncertainty limit a strictly untouched-test interpretation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13212788/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.